Results 221 to 230 of about 57,324 (279)
Oncogenic GPRIN1 sustains proliferation and mitochondrial homeostasis via dual‑layer CDK1-PI3K/Akt signalling in gallbladder cancer. [PDF]
Xu C +7 more
europepmc +1 more source
Heparanase2 inhibits the growth of gallbladder cancer by regulating the VEGF/VEGFR pathway. [PDF]
Cao D +5 more
europepmc +1 more source
The Interplay Between CA19-9 and the Lewis Blood Group System: Implications for the Diagnosis of Gallbladder Cancer. [PDF]
Liu Y +6 more
europepmc +1 more source
Stage-Specific miRNA Profiling Reveals Key Regulators of EMT and EGFR-TKI Resistance in Gallbladder Cancer. [PDF]
Saklani N +5 more
europepmc +1 more source
Postoperative prognostic factors in patients with T2 gallbladder cancer: a meta-analysis. [PDF]
Zuo Y +5 more
europepmc +1 more source
National Cancer Database analysis of gallbladder cancer: Evaluating survival benefit of chemotherapy in early-stage gallbladder cancer. [PDF]
Kim M +5 more
europepmc +1 more source
Gallbladder cancer (GC) is a relatively rare but highly lethal neoplasm. We review the epidemiology, etiology, pathology, symptoms, diagnosis, staging, treatment, and prognosis of GC.A Pubmed database search between 1971 and February 2007 was performed. All abstracts were reviewed and articles with GC obtained; further references were extracted by hand-
Stavros Gourgiotis +2 more
exaly +5 more sources
Gallbladder cancer (GBC) is the most common cancer of the biliary tract, characterized by a very poor prognosis when diagnosed at advanced stages owing to its aggressive behaviour and limited therapeutic options. Early detection at a curable stage remains challenging because patients rarely exhibit symptoms; indeed, most GBCs are discovered ...
Juan C. Roa +5 more
openaire +4 more sources

